false
--12-31
0001736730
0001736730
2024-10-15
2024-10-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 15, 2024
CAMP4 THERAPEUTICS CORPORATION
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-42365 |
|
81-1152476 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
One Kendall Square
Building 1400 West, 3rd Floor
Cambridge, MA |
|
02139 |
(Address of principal executive offices) |
|
(Zip Code) |
(Registrant’s telephone number, including
area code): (617) 651-8867
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Common Stock, par value $0.0001 per share |
|
CAMP |
|
The Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 5.03 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On October 15, 2024, in connection with the consummation of the initial
public offering (the “IPO”) of shares of common stock, par value $0.0001 per share (“Common Stock”), of CAMP4
Therapeutics Corporation (the “Company”), the Company filed a fifth amended and restated certificate of incorporation (the
“Restated Certificate”) with the Secretary of State of the State of Delaware, which became effective upon filing. The Company’s
board of directors and stockholders previously approved the Restated Certificate to be filed in connection with, and to be effective upon,
the consummation of the IPO. The Restated Certificate amends and restates the Company’s fourth amended and restated certificate
of incorporation in its entirety to, among other things, (i) authorize 175 million shares of Common Stock, (ii) eliminate all references
to previously existing series of preferred stock, (iii) authorize 25 million shares of undesignated preferred stock, par value $0.0001
per share, that may be issued from time to time, in one or more series, with the approval of the Company’s board of directors and
(iv) eliminate the ability of the Company’s stockholders to take action by written consent in lieu of a meeting.
The foregoing description of the Restated Certificate is qualified
by reference to the Restated Certificate, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
On October 15, 2024, in connection with the consummation of the IPO,
the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Company’s
board of directors and stockholders, became effective. The Amended and Restated Bylaws amend and restate the Company’s bylaws in
their entirety to, among other things, (i) establish procedures relating to the presentation of stockholder proposals at stockholder meetings,
(ii) establish procedures relating to the nomination of directors, (iii) modify the indemnification provisions for the Company’s
directors and officers, and (iv) conform to the amended provisions of the Restated Certificate.
The foregoing description of the Amended and Restated Bylaws is qualified
by reference to the Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.2 and is incorporated herein by reference.
Item 9.01 |
Financial Statements and Exhibits. |
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
CAMP4 THERAPEUTICS CORPORATION |
|
|
|
|
By: |
/s/ Josh
Mandel-Brehm |
|
|
Name: Josh Mandel-Brehm |
|
|
Title: President and Chief
Executive Officer |
Date: October 15, 2024
Exhibit 3.1
FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
CAMP4 THERAPEUTICS CORPORATION
CAMP4 Therapeutics Corporation, a Delaware corporation (the “Corporation”),
hereby certifies that this Fifth Amended and Restated Certificate of Incorporation has been duly adopted in accordance with Sections 242
and 245 of the General Corporation Law of the State of Delaware (the “DGCL”), and that:
A. The name of the Corporation is: CAMP4 Therapeutics Corporation
B. The Corporation filed its original Certificate of Incorporation
with the Secretary of State of the State of Delaware on September 9, 2015 under the name Marauder Therapeutics, Inc.
C. The Certificate of Incorporation was amended by a Certificate of
Amendment filed on June 9, 2016; a Second Amended and Restated Certificate was filed on April 20, 2018, and such Amended and
Restated Certificate was amended by a Certificate of Amendment filed on May 9, 2019; a Third Amended and Restated Certificate of
Incorporation was filed on March 5, 2021, and such Amended and Restated Certificate was amended by Certificates of Amendment filed
on April 30, 2021; May 5, 2021; July 6, 2021; July 7, 2021; and October 5, 2021; and a Fourth Amended and Restated
Certificate of Incorporation was filed on June 3, 2022, and such Amended and Restated Certificate was amended by a Certificate of
Amendment filed on October 3, 2024.
D. This Fifth Amended and Restated Certificate of Incorporation amends
and restates the Fourth Amended and Restated Certificate of Incorporation of the Corporation as amended by the Certificate of Amendment
filed on October 3, 2024.
E. The Certificate of Incorporation upon the filing of this Fifth Amended
and Restated Certificate of Incorporation, shall read as follows:
ARTICLE I — NAME
The name of the corporation is CAMP4 Therapeutics Corporation (the
“Corporation”).
ARTICLE II — REGISTERED OFFICE AND
AGENT
The address of the Corporation’s registered office in the State
of Delaware is located at the Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle, Delaware,
19801. The name of the Corporation’s registered agent at such address is The Corporation Trust Company.
ARTICLE III — PURPOSE
The purpose of the Corporation is to engage in any lawful act or activity
for which corporations may be organized under the DGCL.
ARTICLE IV — CAPITALIZATION
(a) Authorized Shares. The total number of shares of stock
which the Corporation shall have authority to issue is 200,000,000 shares, consisting of 175,000,000 shares of Common Stock, par value
$0.0001 per share (“Common Stock”) and 25,000,000 shares of Preferred Stock, par value $0.0001 per share (“Preferred
Stock”). Such stock may be issued from time to time by the Corporation for such consideration as may be fixed by the board of
directors of the Corporation (the “Board of Directors”).
(b) Common Stock. Subject to the powers, preferences and
rights of any Preferred Stock, including any series thereof, having any preference or priority over, or rights superior to, the Common
Stock and except as otherwise provided by law and this Article IV, the holders of the Common Stock shall have and possess all powers
and voting and other rights pertaining to the stock of the Corporation.
(i) Voting. Each holder of Common Stock shall be entitled
to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to
vote; provided, that, except as otherwise required by law, holders of Common Stock shall have no voting power with respect to and
shall not be entitled to vote on any amendment to this Restated Certificate of Incorporation (including, but not limited to, any certificate
of designations relating to any series of Preferred Stock) that (A) relates to the issuance of any series of Preferred Stock or (B) relates
solely to the terms of one or more series of Preferred Stock if the holders of such affected series are entitled, either separately or
together with the holders of one or more other such series, to vote thereon pursuant to this Restated Certificate of Incorporation (including,
but not limited to, any certificate of designations relating to any series of Preferred Stock) or pursuant to the DGCL. There shall be
no cumulative voting.
(ii) Dividends. Dividends of cash or property may be declared
and paid on the Common Stock from funds lawfully available therefor as and when determined by the Board of Directors and subject to any
preferential dividend rights of any then outstanding Preferred Stock. Except as otherwise provided by the DGCL or this Restated Certificate
of Incorporation, the holders of record of Common Stock shall share ratably in all dividends payable in cash, stock or otherwise and other
distributions, whether in respect of liquidation or dissolution (voluntary or involuntary) or otherwise.
(iii) No Preemptive Rights. The holders of the Common Stock
shall have no preemptive rights to subscribe for any shares of any class of stock of the Corporation whether now or hereafter authorized.
(iv) No Conversion Rights. The Common Stock shall not be
convertible into, or exchangeable for, shares of any other class or classes or of any other series of the same class of the Corporation’s
capital stock.
(v) Liquidation Rights. Upon the dissolution, liquidation
or winding up of the affairs of the Corporation, whether voluntary or involuntary, after payment or provision for payment of the debts
and liabilities of the Corporation and of the preferential and other amounts, if any, to which the holders of Preferred Stock shall be
entitled, holders of Common Stock shall be entitled to receive all assets of the Corporation available for distribution to its stockholders,
ratably in proportion to the number of shares held by each such stockholder. A merger or consolidation of the Corporation with or into
any other corporation or other entity or a sale or conveyance of all or any part of the assets of the Corporation, in any such case that
does not in fact result in the liquidation of the Corporation and the distribution of assets to its stockholders, shall not be deemed
to be a voluntary or involuntary liquidation or dissolution or winding up of the Corporation within the meaning of this Article IV(b)(v).
(c) Preferred Stock. Shares of Preferred Stock may be issued
in one or more series, from time to time, with each such series to consist of such number of shares and to have such voting powers relative
to other classes or series of Preferred Stock, if any, or Common Stock, full or limited or no voting powers, and such designations, preferences
and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, as shall be stated
in the resolution or resolutions providing for the issuance of such series adopted by the Board of Directors, and the Board of Directors
is hereby expressly vested with the authority, to the full extent now or hereafter provided by applicable law, to adopt any such resolution
or resolutions. Except as otherwise provided in this Restated Certificate of Incorporation, no vote of the holders of the Preferred Stock
or Common Stock shall be a prerequisite to the designation or issuance of any shares of any series of the Preferred Stock authorized by
and complying with the conditions of this Restated Certificate of Incorporation, the right to have such vote being expressly waived by
all present and future holders of the capital stock of the Corporation. Any shares of Preferred Stock that are redeemed, purchased or
acquired by the Corporation may be reissued except as otherwise provided by law or this Restated Certificate of Incorporation, including
the certificate of designations for such Preferred Stock. Different series of Preferred Stock shall not be construed to constitute different
classes of shares for the purposes of voting by classes unless expressly provided in the resolution or resolutions providing for the issue
of such series adopted by the Board of Directors.
(d) No Class Vote on Changes in Authorized Number of Shares
of Preferred Stock. Subject to the special rights of the holders of any series of Preferred Stock pursuant to the terms of this Restated
Certificate of Incorporation, any certificate of designations or any resolution or resolutions providing for the issuance of such series
of stock adopted by the Board of Directors, the number of authorized shares of Preferred Stock may be increased or decreased (but not
below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the stock of the Corporation
entitled to vote irrespective of the provisions of Section 242(b)(2) of the DGCL.
ARTICLE V — BOARD OF DIRECTORS
(a) Number of Directors; Vacancies and Newly-Created Directorships.
The number of directors constituting the Board of Directors shall be not fewer than three (3) and not more than fifteen (15), each
of whom shall be a natural person. Subject to the previous sentence and to the special rights of the holders of any class or series of
Preferred Stock to elect directors, the precise number of directors shall be fixed exclusively pursuant to a resolution adopted by the
Board of Directors. Vacancies and newly-created directorships shall be filled exclusively pursuant to a vote of a majority of the directors
then in office, even if less than a quorum, or by a sole remaining director, except that any vacancy created by the removal of a director
by the stockholders for cause shall be filled, in addition to any other vote otherwise required by law, only by vote of a majority of
outstanding shares of Common Stock. No decrease in the number of directors constituting the Board of Directors shall shorten the term
of any incumbent director. A director elected to fill a vacancy shall be elected for the unexpired term of his or her predecessor in office,
and a director chosen to fill a position resulting from an increase in the number of directors shall hold office until the next election
of the class for which such director shall have been chosen, subject to the election and qualification of his or her successor and to
his or her earlier death, resignation or removal. Subject to the special rights of any holder of any class or series of Preferred Stock
to elect directors, the directors of the Corporation may be removed only for cause by the affirmative vote of the holders of at least
seventy-five percent (75%) of the voting power of the outstanding shares of capital stock of the Corporation entitled to vote generally
in the election of directors, voting together as a single class, at a meeting of the stockholders called for that purpose.
(b) Classified Board of Directors. Subject to the special
rights of the holders of any class or series of Preferred Stock to elect directors, the Board of Directors shall be classified with respect
to the time for which directors severally hold office into three classes. The initial Class I Directors shall serve for a term expiring
at the first annual meeting of stockholders of the Corporation following the filing of this Restated Certificate of Incorporation; the
initial Class II Directors shall serve for a term expiring at the second annual meeting of stockholders following the filing of this
Restated Certificate of Incorporation; and the initial Class III Directors shall serve for a term expiring at the third annual meeting
of stockholders following the filing of this Restated Certificate of Incorporation. Each director in each class shall hold office until
his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal. At each annual meeting of
stockholders beginning with the first annual meeting of stockholders following the filing of this Restated Certificate of Incorporation,
the successors of the class of directors whose term expires at that meeting shall be elected to hold office for a term expiring at the
annual meeting of stockholders to be held in the third year following the year of their election, with each director in each such class
to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.
ARTICLE VI — LIMITATION OF LIABILITY;
INDEMNIFICATION AND ADVANCEMENT OF EXPENSES
(a) Limitation of Liability. To the fullest extent that
the DGCL or any other law of the State of Delaware (as the law exists on the date hereof or as the law may hereafter be amended) permits
the limitation or elimination of the liability of directors or officers, no director or officer of the Corporation shall be liable to
the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable. No amendment
to, or modification or repeal of, this Article VI(a) shall adversely affect any right or protection of a director or officer
of the Corporation existing hereunder with respect to any state of facts existing or act or omission occurring, or any cause of action,
suit or claim that, but for this Article VI, would accrue or arise, prior to such amendment, modification or repeal. If, after this
Restated Certificate of Incorporation is filed with the Secretary of State of the State of Delaware, the DGCL or such other law is amended
to authorize corporate action further eliminating or limiting the personal liability of directors or officer, then the liability of a
director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL or such other law, as
so amended.
(b) Indemnification and Advancement of Expenses to Directors
and Officers. The Corporation shall indemnify and advance expenses to, and hold harmless, to the fullest extent permitted by applicable
law as it presently exists or may hereafter be amended, any person (an “Indemnitee”) who was or is made, or is threatened
to be made, a party or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (a “Proceeding”), by reason of the fact that he or she, or a person for whom he or
she is the legal representative, is or was a director or an officer of the Corporation appointed as an officer by the Board of Directors
or, while a director or such an officer of the Corporation, is or was serving at the request of the Corporation as a director, officer,
employee, member, trustee or agent of another corporation or of a partnership, joint venture, trust, nonprofit entity or other enterprise
(including, but not limited to, service with respect to employee benefit plans), against all liability and loss suffered (including, but
not limited to, expenses (including, but not limited to, attorneys’ fees and expenses), judgments, fines and amounts paid in settlement
and reasonably incurred by such Indemnitee). Notwithstanding the preceding sentence, the Corporation shall be required to indemnify, or
advance expenses to, an Indemnitee in connection with a Proceeding (or part thereof) commenced by such Indemnitee only if the commencement
of such Proceeding (or part thereof) by the Indemnitee was authorized by the Board of Directors of the Corporation or the Proceeding (or
part thereof) relates to the enforcement of the Corporation’s obligations under this Article VI(b).
(c) Indemnification and Advancement of Expenses to Employees
and Agents. The Corporation may indemnify and advance expenses to any person who was or is made, or is threatened to be made, a party
or is otherwise involved in any Proceeding by reason of the fact that such person, or a person for whom such person is the legal representative,
is or was an employee or agent of the Corporation or, while an employee or agent of the Corporation, is or was serving at the request
of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, limited liability
company, trust, enterprise or nonprofit entity, including, but not limited to, service with respect to employee benefit plans, against
all liability and loss suffered and expenses (including, but not limited to, attorneys’ fees) reasonably incurred by such person
in connection with such Proceeding. The ultimate determination of entitlement to indemnification of persons who are not directors or officers
of the Corporation shall be made in such manner as is determined by the Board of Directors in its sole discretion.
(d) Insurance. The Corporation may purchase and maintain
insurance on behalf of any person who is or was a director, officer, trustee, employee or agent of the Corporation, or was serving at
the request of the Corporation as a director, officer, trustee, employee or agent of another corporation, partnership, joint venture,
trust, non-profit entity or other enterprise (including, but not limited to, service with respect to employee benefit plans), against
any liability asserted against the person and incurred by the person in any such capacity, or arising out of his or her status as such,
whether or not the Corporation would have the power or the obligation to indemnify such person against such liability under the provisions
of this Article VI.
(e) Non-Exclusivity of Rights. The indemnification provided
by this Article VI is not exclusive of other indemnification rights arising under any bylaw, agreement, vote of directors or stockholders
or otherwise, and shall inure to the benefit of the heirs and legal representatives of such Indemnitee.
(f) Indemnification Priority. As between the Corporation
and affiliates of the Corporation (other than its direct or indirect subsidiaries) who provide indemnification to the Indemnitees for
their service to, or on behalf of, the Corporation (collectively, the “Affiliate Indemnitors”) (i) the Corporation
is the indemnitor of first resort with respect to all claims indemnifiable pursuant to Article VI(b) against any such Indemnitee
(i.e., the Corporation’s obligations to such Indemnitees are primary and any obligation of any Affiliate Indemnitor to advance expenses
or to provide indemnification for the same loss or liability incurred by such Indemnitees is secondary), (ii) the Corporation shall
be required to advance the full amount of expenses incurred by any such Indemnitee and shall be liable for the full amount of all liability
and loss suffered by such Indemnitee (including, but not limited to, expenses (including, but not limited to, attorneys’ fees and
expenses), judgments, fines and amounts paid in settlement and reasonably incurred by such Indemnitee), without regard to any rights any
such Indemnitee may have against any Affiliate Indemnitor and (iii) the Corporation irrevocably waives, relinquishes and releases
each Affiliate Indemnitor from any and all claims against such Affiliate Indemnitor for contribution, subrogation or any other recovery
of any kind in respect thereof. The Corporation shall indemnify each Affiliate Indemnitor directly for any amounts that such Affiliate
Indemnitor pay as indemnification or advancement on behalf of any such Indemnitee and for which such Indemnitee may be entitled to indemnification
from the Corporation pursuant to Article VI(b). No advancement or payment by any Affiliate Indemnitor on behalf of any such Indemnitee
with respect to any claim for which such Indemnitee has sought indemnification from the Corporation shall affect the foregoing, and the
Affiliate Indemnitors shall be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Indemnitee
against the Corporation.
ARTICLE VII — MEETINGS OF STOCKHOLDERS
(a) No Action by Written Consent. Except as otherwise provided
for or fixed by or pursuant to the provisions of this Restated Certificate of Incorporation or any resolution or resolutions of the Board
of Directors providing for the issuance of Preferred Stock, any action required or permitted to be taken by the stockholders of the Corporation
may be effected only at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent
in writing by such stockholders.
(b) Special Meetings of Stockholders. Subject to the special
rights of the holders of any series of Preferred Stock, and to the requirements of applicable law, special meetings of stockholders of
the Corporation may be called only by the Board of Directors pursuant to a resolution adopted by a majority of the total number of directors
which the Corporation would have if there were no vacancies.
(c) Election of Directors by Written Ballot. Election of
directors need not be by written ballot.
ARTICLE VIII — AMENDMENTS TO THE
BYLAWS AND
RESTATED CERTIFICATE OF INCORPORATION
(a) Bylaws. In furtherance and not in limitation of the
powers conferred by law, the Board of Directors is expressly authorized to make, alter, amend or repeal the bylaws of the Corporation
(the “Bylaws”) subject to the power of the stockholders of the Corporation to alter, amend or repeal the Bylaws; provided,
that with respect to the powers of stockholders to make, alter, amend or repeal the Bylaws, the affirmative vote of the holders of at
least seventy-five percent (75%) of the voting power of the outstanding shares of capital stock of the Corporation entitled to vote with
respect thereto, voting together as a single class, shall be required to alter, amend or repeal the bylaws of the Corporation.
(b) Amendments to the Certificate of Incorporation. The
Corporation reserves the right to amend, alter, change or repeal any provision contained in this Restated Certificate of Incorporation
in the manner now or hereafter prescribed by the DGCL, and all rights conferred upon stockholders herein are granted subject to this reservation.
Notwithstanding anything to the contrary contained in this Restated Certificate of Incorporation, and notwithstanding that a lesser percentage
may be permitted from time to time by applicable law, no provision of paragraph (c) of Article IV, Article V, Article VI,
paragraphs (a) and (b) of Article VII and this Article VIII may be altered, amended or repealed in any respect, nor
may any provision or bylaw inconsistent therewith be adopted, unless, in addition to any other vote required by this Restated Certificate
of Incorporation or otherwise required by law, such alteration, amendment, repeal or adoption is approved by the affirmative vote of the
holders of at least seventy-five percent (75%) of the voting power of the outstanding shares of capital stock of the Corporation entitled
to vote generally in the election of directors, voting together as a single class, at a meeting of the stockholders called for that purpose.
ARTICLE IX — EXCLUSIVE JURISDICTION
FOR CERTAIN ACTIONS
(a) Exclusive Forum. Unless the Board of Directors or one
of its committees otherwise approves the selection of an alternate forum, the Court of Chancery of the State of Delaware (or, if, and
only if, the Court of Chancery of the State of Delaware dismisses a Covered Claim (as defined below) for lack of subject matter jurisdiction,
any other state or federal court in the State of Delaware that does have subject matter jurisdiction) shall, to the fullest extent permitted
by applicable law, be the sole and exclusive forum for any (i) derivative claim brought in the right of the Corporation, (ii) claim
asserting a breach of a fiduciary duty to the Corporation or the Corporation’s stockholders owed by any current or former director,
officer or other employee or stockholder of the Corporation, (iii) claim against the Corporation arising pursuant to any provision
of the DGCL, this Restated Certificate of Incorporation or the Amended and Restated Bylaws, (iv) claim to interpret, apply, enforce
or determine the validity of this Restated Certificate of Incorporation or the Amended and Restated Bylaws, (v) claim against the
Corporation governed by the internal affairs doctrine, or (vi) other claim, not subject to exclusive federal jurisdiction and not
subject to paragraph (d) below, brought in any action asserting one or more of the claims specified in clauses (a)(i) through
(v) herein above (each a “Covered Claim”); provided, however, that the provisions of this Article IX(a) will
not apply to claims brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended or any other claim
for which the federal courts have exclusive jurisdiction.
(b) Personal Jurisdiction. If any person or entity (a “Claiming
Party”) files an action asserting a Covered Claim in a court other than one determined in accordance with paragraph (a) above
(each a “Foreign Action”) without the prior approval of the Board of Directors or committees of the Board of Directors
delegated authority to make such determination, such Claiming Party shall be deemed to have consented to (i) the personal jurisdiction
of the court determined in accordance with paragraph (a) in connection with any such action brought in any such court to enforce
paragraph (a) (an “Enforcement Action”) and (ii) having service of process made upon such Claiming Party
in any such Enforcement Action by service upon such Claiming Party’s counsel in the Foreign Action as agent for such Claiming Party.
(c) Notice and Consent. Any person or entity purchasing
or otherwise acquiring any interest in the shares of capital stock of the Corporation shall be deemed to have notice of and consented
to the provisions of this Article IX and waived any argument relating to the inconvenience of the forums referenced above in connection
with any Covered Claim.
(d) Federal Forum. Unless the Corporation consents in writing
to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution
of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Any person or entity purchasing or
otherwise acquiring any interest in any security of the Corporation shall be deemed to have notice of and consented to this provision.
ARTICLE X — SEVERABILITY
If any provision or provisions of this Restated Certificate of Incorporation
shall be held to be invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever: (i) the validity,
legality and enforceability of such provision or provisions in any other circumstance and of the remaining provisions of this Restated
Certificate of Incorporation (including, but not limited to, each portion of any paragraph of this Restated Certificate of Incorporation
containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable)
shall not in any way be affected or impaired thereby and (ii) to the fullest extent possible, the provisions of this Restated Certificate
of Incorporation (including, but not limited to, each such portion of any paragraph of this Restated Certificate of Incorporation containing
any such provision held to be invalid, illegal or unenforceable) shall be construed so as to permit the Corporation to protect its directors,
officers, employees and agents from personal liability in respect of their good faith service to or for the benefit of the Corporation
to the fullest extent permitted by law.
[Remainder of Page Intentionally Left Blank
– Signature Page Follows]
IN WITNESS WHEREOF, the undersigned has caused this Fifth Amended
and Restated Certificate of Incorporation to be executed by the officer below this 15th day of October, 2024.
|
CAMP4 Therapeutics
Corporation |
|
|
|
|
By: |
/s/
Josh Mandel-Brehm |
|
Name: |
Josh
Mandel-Brehm |
|
Title: |
Chief
Executive Officer |
Exhibit 3.2
CAMP4 THERAPEUTICS CORPORATION
AMENDED AND RESTATED BYLAWS
SECTION 1 - STOCKHOLDERS
Section 1.1. Annual Meeting.
An annual meeting of the stockholders of CAMP4 Therapeutics Corporation,
a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for
the transaction of such other business as may properly come before the meeting shall be held at the place, if any, within or without the
State of Delaware, on the date and at the time that the board of directors of the Corporation (the “Board of Directors”)
shall each year fix. Unless stated otherwise in the notice of the annual meeting of the stockholders of the Corporation, such annual meeting
shall be at the principal office of the Corporation. The Board of Directors may, in its sole discretion, determine that the meeting shall
not be held at any place, but may instead be held solely or in part by any permissible means of remote communication, including electronic
transmission or telephonic means (a “virtual meeting”) in accordance with the General Corporation Law of the State
of Delaware (the “DGCL”).
Section 1.2. Advance Notice of Nominations and Proposals of
Business.
(a) Nominations of persons for election to the Board of Directors
and proposals for other business to be transacted by the stockholders at an annual meeting of stockholders may be made (i) pursuant
to the Corporation’s notice with respect to such meeting (or any supplement thereto), (ii) by or at the direction of the Board
of Directors or (iii) by any stockholder of record of the Corporation who (A) was a stockholder of record at the time of the
giving of the notice contemplated in Section 1.2(b), (B) is entitled to vote at such meeting, (C) has complied with the
notice procedures set forth in this Section 1.2, and (D) to the extent that Rule 14a-19 under the Securities Exchange Act
of 1934 (as amended from time to time, the “Exchange Act”) applies, has complied with Rule 14a-19 under the Exchange
Act. Subject to Section 1.2(h) and except as otherwise required by law, clause (iii) of this Section 1.2(a) shall
be the exclusive means for a stockholder to make nominations or propose other business (other than nominations and proposals properly
brought pursuant to applicable provisions of federal law, including the Exchange Act and the rules and regulations of the Securities
and Exchange Commission (the “SEC”) thereunder), before an annual meeting of stockholders.
(b) Except as otherwise required by law, for nominations or proposals
to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of Section 1.2(a), (i) the stockholder
must have given timely notice thereof in writing to the Secretary of the Corporation with the information contemplated by Section 1.2(c),
including, where applicable, delivery to the Corporation of timely and completed questionnaires as contemplated by Section 1.2(c),
and (ii) the business must be a proper matter for stockholder action under the DGCL. The notice requirements of this Section 1.2
shall be deemed satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the Corporation
of his, her or its intention to present a proposal at an annual meeting in compliance with applicable rules and regulations promulgated
under the Exchange Act and such stockholder’s proposal has been included in a proxy statement prepared by the Corporation to solicit
proxies for such annual meeting.
(c) To
be timely for purposes of Section 1.2(b), a stockholder’s notice must be delivered to the Secretary of the Corporation at the
principal executive offices of the Corporation on a date (i) not later than the close of business on the ninetieth (90th)
day nor earlier than the close of business on the one hundred twentieth (120th) day prior to the
anniversary date of the prior year’s annual meeting, (ii) with respect to the Corporation’s 2025 annual meeting, during
February 2025, (iii) or if there was no annual meeting in the prior year or if the date of the current year’s annual meeting
is more than thirty (30) days before or after the anniversary date of the prior year’s annual meeting, on or before ten (10) days
after the day on which the date of the current year’s annual meeting is first disclosed in a public announcement. In no event shall
any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the delivery of such notice.
For the avoidance of doubt, a stockholder shall not be entitled to make additional or substitute nominations following the expiration
of the time periods set forth in these bylaws. The notice from a stockholder must state (a) as to each nominee that the stockholder
proposes for election or reelection as a director, (A) all information relating to such nominee that would be required to be disclosed
in solicitations of proxies for the election of such nominee as a director pursuant to Regulation 14A under the Exchange Act and such
nominee’s written consent to serve as a director if elected, and (B) a description of all direct and indirect compensation
and other material monetary arrangements, agreements or understandings during the past three years, and any other material relationship,
if any, between or concerning such stockholder, any Stockholder Associated Person (as defined below) or any of their respective affiliates
or associates, on the one hand, and the proposed nominee or any of his or her respective affiliates or associates, on the other hand;
(b) as to each proposal that the stockholder seeks to bring before the meeting, the text of the proposal (including the text of any
resolutions proposed for consideration and, in the event that it includes a proposal to amend the bylaws of the Corporation, the language
of the proposed amendment), a brief description of such proposal, the reasons for making the proposal at the meeting, and any direct or
indirect material interest that the stockholder or any Stockholder Associated Person has in the proposal; and (c) (A) the name
and address of the stockholder giving the notice and the Stockholder Associated Persons, if any, on whose behalf the nomination or proposal
is made, (B) the class (and, if applicable, series) and number of shares of capital stock of the Corporation that are, directly or
indirectly, owned beneficially or of record by the stockholder or any Stockholder Associated Person, (C) any option, warrant, convertible
security, stock appreciation right or similar instrument, right, agreement, arrangement or understanding with an exercise or conversion
privilege or a settlement payment or mechanism at a price related to any class (or, if applicable, series) of shares of capital stock
of the Corporation or with a value derived in whole or in part from the value of any class (or, if applicable, series) of shares of capital
stock of the Corporation, whether or not such instrument, right, agreement, arrangement or understanding shall be subject to settlement
in the underlying class or series of capital stock of the Corporation or otherwise, and any other direct or indirect opportunity to profit
or share in any profit derived from any increase or decrease in the value of shares of capital stock of the Corporation (each, a “Derivative
Instrument”) directly or indirectly owned beneficially or of record by such stockholder or any Stockholder Associated Person,
(D) any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder or any Stockholder Associated
Person has a right to vote any securities of the Corporation, (E) any proportionate interest in shares of the Corporation or Derivative
Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder or any Stockholder Associated
Person is a general partner or beneficially owns, directly or indirectly, an interest in a general partner, (F) any performance-related
fees (other than an asset-based fee) that such stockholder or any Stockholder Associated Person is entitled to based on any increase or
decrease in the value of the shares of capital stock of the Corporation or Derivative Instruments, (G) any direct or indirect material
legal, economic or financial interest of the stockholder or any Stockholder Associated Person in the outcome of any vote to be taken at
any annual or special meeting of stockholders of the Corporation, (H) any other information relating to such stockholder or any Stockholder
Associated Person, if any, required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations
of proxies for, as applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance
with Section 14(a) of the Exchange Act and the rules and regulations of the SEC thereunder, (I) a representation that
the stockholder is a holder of record of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy
at the meeting to propose such business or nomination and has complied with the provisions of this Section 1.2(c), and (J) whether
the stockholder intends to (x) deliver a proxy statement and form of proxy to holders of, in the case of a proposal, at least the
percentage of the Corporation’s voting shares required under applicable law to carry the proposal or, in the case of a nomination
or nominations, a sufficient number of holders of the Corporation’s voting shares reasonably believed by such stockholder to be
sufficient to elect such nominee or nominees, (y) solicit proxies in support of director nominees other than persons nominated by
or at the direction of the Board of Directors or any committee thereof, in accordance with Rule 14a-19 under the Exchange Act or
(z) otherwise to solicit proxies or votes from stockholders in support of such proposal or nomination (and, if so, a color other
than white of the form of proxy intended to be used). For purposes of these bylaws, (i) a “Stockholder Associated Person”
with respect to any stockholder means (A) any “affiliate” or “associate” (as those terms are defined in Rule 12b-2
under the Exchange Act) of such stockholder, (B) any beneficial owner of any capital stock or other securities of the Corporation
owned of record by such stockholder, and (C) any person directly or indirectly controlling, controlled by or under common control
with any such Stockholder Associated Person referred to in clause (A) or (B) above, and (ii) “beneficial ownership”
shall be determined in accordance with Rule 13d-3 promulgated under the Exchange Act. In addition, in order for a nomination to be
properly brought before an annual or special meeting by a stockholder pursuant to clause (iii) of Section 1.2(a), any nominee
proposed by a stockholder shall complete a questionnaire, in a form provided by the Corporation, and deliver a signed copy of such completed
questionnaire to the Corporation within ten (10) days of the date that the Corporation makes available to the stockholder seeking
to make such nomination or such nominee the form of such questionnaire. The Corporation may require any proposed nominee to furnish such
other information as may be reasonably requested by the Corporation to determine the eligibility of the proposed nominee to serve as an
independent director of the Corporation or that could be material to a reasonable stockholder’s understanding of the independence,
or lack thereof, of the nominee. The information required to be included in a notice pursuant to this Section 1.2(c) shall be
provided as of the date of such notice. A stockholder shall further update and supplement its notice of any nomination to be brought before
a meeting, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 1.2
shall be true and correct in all material respects (i) as of the record date for the meeting and (ii) as of the date that is
ten (10) business days prior to the meeting or any adjournment, recess, rescheduling or postponement thereof. Any such update or
supplement shall be delivered to the Secretary of the Corporation (i) not later than three (3) business days after the later
of (A) the record date and (B) the date notice of the record date is first publicly announced (in the case of the update and
supplement required to be made as of the record date for the meeting) and (ii) not later than seven (7) business days prior
to (A) the date for the meeting, if practicable (or, if not practicable, on the first practicable date prior to the meeting), or
(B) any adjournment, recess, rescheduling or postponement thereof (in the case of the update and supplement required to be made as
of ten (10) business days prior to the meeting or any adjournment, recess, rescheduling or postponement thereof). For the avoidance
of doubt, any information provided in such update or supplement shall not be deemed to cure any deficiencies in a notice previously delivered
pursuant to this Section 1.2(c) and shall not extend the time period for the delivery of notice pursuant to this Section 1.2(c).
If a stockholder giving notice fails to provide such update or supplement within the required period, the information as to which such
update or supplement relates may be deemed not to have been provided in accordance with this Section 1.2(c). The information required
to be included in a notice pursuant to this Section 1.2(c) shall not include any ordinary course business activities of any
broker, dealer, commercial bank, trust company or other nominee who is directed to prepare and submit the notice required by this Section 1.2(c) on
behalf of a beneficial owner of the shares held of record by such broker, dealer, commercial bank, trust company or other nominee and
who is not otherwise affiliated with such beneficial owner.
(d) Subject to the certificate of incorporation of the Corporation
(the “Certificate of Incorporation”), Section 1.2(i) and applicable law, only persons nominated in accordance
with the procedures stated in this Section 1.2 shall be eligible for election as and to serve as members of the Board of Directors,
and the only business that shall be conducted at an annual meeting of stockholders is the business that has been brought before the meeting
in accordance with the procedures set forth in this Section 1.2. The chairperson of the meeting shall have the power and the duty
to determine whether a nomination or any proposal has been made according to the procedures stated in this Section 1.2 and, if the
chairperson of the meeting determines that any nomination or proposal does not comply with this Section 1.2, unless otherwise required
by law, the chairperson of the meeting is authorized to disregard the nomination or proposal.
(e) For purposes of this Section 1.2, “public announcement”
means disclosure in a press release reported by the Dow Jones News Service, Associated Press or a comparable news service or in a document
publicly filed or furnished by the Corporation with or to the SEC pursuant to Section 13, 14 or 15(d) of the Exchange Act.
(f) Notwithstanding the foregoing provisions of this Section 1.2,
a stockholder shall also comply with applicable requirements of the Exchange Act and the rules and regulations thereunder with respect
to matters set forth in this Section 1.2. Nothing in this Section 1.2 shall affect any rights, if any, of stockholders to request
inclusion of nominations or proposals in the Corporation’s proxy statement pursuant to applicable provisions of federal law, including
the Exchange Act.
(g) Notwithstanding the foregoing provisions of this Section 1.2,
unless otherwise required by law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual
or special meeting of stockholders of the Corporation to present a nomination or proposed business or does not provide the information
required by Section 1.2(c), including any required supplement thereto, the chairperson of the meeting is authorized to disregard
such nomination or proposal, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes
of this Section 1.2, to be considered a qualified representative of the stockholder, a person must be a duly authorized officer,
manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered
by such stockholder to act for such stockholder as proxy at the meeting of stockholders, and such person must produce such writing or
electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders.
(h) Only such business shall be conducted at a special meeting
of stockholders as shall have been brought before the meeting pursuant to the Corporation’s notice of meeting. Nominations of persons
for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant
to the Corporation’s notice of meeting (i) by or at the direction of the Board of Directors or any committee thereof or (ii) provided
that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of the Corporation who
is a stockholder of record at the time the notice provided for in this Section 1.2 is delivered to the Secretary of the Corporation,
who is entitled to vote at the meeting upon such election and who complies with the notice procedures set forth in this Section 1.2.
In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of
Directors, any such stockholder entitled to vote in such election of directors may nominate a person of persons (as the case may be) for
election to such position(s) as specified in the Corporation’s notice of meeting, if the stockholder’s notice required
by paragraph (b) of this Section 1.2 shall be delivered to the Secretary of the Corporation not earlier than the close of business
on the one hundred twentieth (120th) day prior to such special meeting and not later than the close of business on the later of the ninetieth
(90th) day prior to such special meeting or the tenth (10th) day following the day on which public announcement is first made of the date
of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. In no event shall the public
announcement of an adjournment or postponement of a special meeting commence a new time period (or extend any time period) for the giving
of a stockholder’s notice as described above.
(i) All provisions of this Section 1.2 are subject to, and
nothing in this Section 1.2 shall in any way limit the exercise, or the method or timing of the exercise of, the rights of any person
granted by the Corporation to nominate directors, which rights may be exercised without compliance with the provisions of this Section 1.2.
(j) Without limiting any other provisions and requirements of
this Section 1.2, unless otherwise required by law, if (i) any stockholder provides notice pursuant to Rule 14a-19(b) under
the Exchange Act (for the avoidance of doubt, such notice must be delivered within the time period provided for in Section 1.2(c) to
be considered timely) and (ii) such stockholder subsequently either (A) notifies the Corporation that such stockholder no longer
intends to solicit proxies in support of director nominees other than the Corporation’s nominees in accordance with Rule 14a-19
under the Exchange Act or (B) fails to comply with the requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) under
the Exchange Act, then such stockholder’s nominations shall be deemed null and void and the Corporation shall disregard any proxies
or votes solicited for such stockholder’s nominees. If any stockholder provides notice pursuant to Rule 14a-19(b) under
the Exchange Act, such stockholder shall, upon request of the Corporation, deliver to the Corporation, no later than five (5) business
days prior to the applicable meeting, reasonable evidence that it has met the requirements of Rule 14a-19(a)(3) under the Exchange
Act.
Section 1.3. Special Meetings; Notice.
Special meetings of the stockholders of the Corporation may be called
only to the extent and in the manner set forth in the Certificate of Incorporation. Notice of every special meeting of the stockholders
of the Corporation shall state the purpose or purposes of such meeting. Except as otherwise required by law, the business conducted at
a special meeting of stockholders of the Corporation shall be limited exclusively to the business set forth in the Corporation’s
notice of meeting, and the individual or group calling such meeting shall have exclusive authority to determine the business included
in such notice.
Section 1.4. Notice of Meetings.
Notice of the place, if any, date and time of all meetings of stockholders
of the Corporation, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the
record date for stockholders entitled to notice of the meeting) and the means of remote communications, if any, by which stockholders
and proxy holders may be deemed present and vote at such meeting, and, in the case of all special meetings of stockholders, the purpose
or purposes of the meeting, shall be given, not less than ten (10) nor more than sixty (60) days before the date on which such meeting
is to be held (unless a different time is specified by law or applicable rule or regulation), to each stockholder entitled to notice
of the meeting.
The Corporation may postpone or cancel any previously called annual
or special meeting of stockholders of the Corporation by making a public announcement (as defined in Section 1.2(e)) of such postponement
or cancellation prior to the meeting. When a previously called annual or special meeting is postponed to another time, date or place,
if any, notice of the place (if any), date and time of the postponed meeting, the record date for determining the stockholders entitled
to vote at the meeting (if such date is different from the record date for stockholders entitled to notice of the meeting) and the means
of remote communications, if any, by which stockholders and proxy holders may be deemed present and vote at such postponed meeting, shall
be given in conformity with this Section 1.4 unless such meeting is postponed to a date that is not more than sixty (60) days after
the date that the initial notice of the meeting was provided in conformity with this Section 1.4.
When a meeting is adjourned to another time or place, notice need not
be given of the adjourned meeting if the time and place, if any, thereof and the means of remote communication, if any, by which stockholders
and proxy holders may be deemed to be present and vote at such adjourned meeting are provided in accordance with the DGCL; provided,
however, that if the adjournment is for more than thirty (30) days, a notice of the adjourned meeting shall be given to each stockholder
of record entitled to vote at the meeting, or if after the adjournment a new record date for stockholders entitled to vote is fixed for
the adjourned meeting the Board of Directors shall fix a new record date for notice of such adjourned meeting in conformity herewith and
such notice shall be given to each stockholder of record entitled to vote at such adjourned meeting as of the record date for notice of
such adjourned meeting. At any adjourned meeting, any business may be transacted that may have been transacted at the original meeting.
Section 1.5. Quorum.
At any meeting of the stockholders, the holders of shares of capital
stock of the Corporation entitled to cast a majority of the total votes entitled to be cast by the holders of all outstanding shares of
capital stock of the Corporation entitled to vote generally in the election of directors, present in person or by proxy, shall constitute
a quorum for all purposes, unless or except to the extent that the presence of a larger number is required by applicable law or the Certificate
of Incorporation. If a separate vote by one or more classes or series is required, the holders of shares entitled to cast a majority of
the total votes entitled to be cast by the holders of the shares of the class or classes or series, present in person or represented by
proxy, shall constitute a quorum entitled to take action with respect to the vote on that matter. A quorum, once established, shall not
be deemed to cease to exist due to the subsequent withdrawal prior to the closing of the meeting of the Corporation’s voting shares
that would result in less than a quorum remaining present in person or by proxy at such meeting. For the purposes of the immediately preceding
sentence, an adjournment of a meeting shall not constitute the closing of such meeting.
If a quorum shall fail to attend any meeting, the chairperson of the
meeting may adjourn the meeting to another place, if any, date and time. At any such adjourned meeting at which there is a quorum, any
business may be transacted that might have been transacted at the meeting originally called.
Section 1.6. Organization.
The Chairperson of the Board of Directors or, in his or her absence,
the person whom the Board of Directors designates or, in the absence of that person or the failure of the Board of Directors to designate
a person, the Chief Executive Officer of the Corporation or, in the Chief Executive Officer’s absence, the person chosen by the
holders of a majority of the shares of capital stock entitled to vote who are present, in person or by proxy, shall call to order any
meeting of the stockholders of the Corporation and act as chairperson of the meeting. In the absence of the Secretary or any Assistant
Secretary of the Corporation, the secretary of the meeting shall be the person the chairperson appoints.
Section 1.7. Conduct of Business.
The chairperson of any meeting of stockholders of the Corporation shall
determine the order of business and the rules of procedure for the conduct of such meeting, including the manner of voting and the
conduct of discussion as he or she determines to be in order. The chairperson shall have the power to adjourn the meeting to another place,
if any, date and time. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote
at the meeting shall be announced at the meeting. Except to the extent inconsistent with such rules and regulations as adopted by
the Board of Directors, the chairperson of the meeting shall have the right and authority to convene and (for any or no reason) to adjourn
the meeting, to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairperson, are
appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or
prescribed by the chairperson of the meeting, may include, without limitation, the following: (i) the establishment of an agenda
or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety of those
present; (iii) limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their
duly authorized and constituted proxies or such other persons as the chairperson of the meeting shall determine; (iv) restrictions
on entry to the meeting after the time fixed for the commencement thereof; and (v) limitations on the time allotted to questions
or comments by participants. The chairperson of the meeting of stockholders, in addition to making any other determinations that may be
appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to the meeting that a nomination or matter
of business was not properly brought before the meeting and, if such chairperson should so determine, such chairperson shall so declare
to the meeting, and any such matter or business not properly brought before the meeting shall not be transacted or considered. Unless
and to the extent determined by the Board of Directors or the chairperson of the meeting, meetings of stockholders shall not be required
to be held in accordance with the rules of parliamentary procedure.
Section 1.8. Proxies; Inspectors.
(a) At any meeting of the stockholders, every stockholder entitled
to vote may vote in person or by proxy authorized by an instrument in writing or by a transmission permitted by applicable law, but no
such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. A proxy
shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law
to support an irrevocable power. A stockholder may revoke any proxy that is not irrevocable by attending the meeting and voting in person
or by delivering to the Secretary of the Corporation a revocation of the proxy or a new proxy bearing a later date. Any stockholder directly
or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for exclusive
use by the Corporation.
(b) Prior to a meeting of the stockholders of the Corporation,
the Corporation shall appoint one or more inspectors, who may be employees of the Corporation, to act at a meeting of stockholders of
the Corporation and make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace
any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairperson of the meeting
may, and to the extent required by applicable law, shall, appoint one or more inspectors to act at the meeting. Each inspector, before
beginning the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality
and according to the best of his or her ability. A inspector may appoint or retain other persons or entities to assist the inspector in
the performance of the duties of the inspector. The inspector shall have the duties prescribed by applicable law. No ballot, proxies,
votes or any revocation thereof or change thereto shall be accepted by the inspector after the closing of the polls unless the Court of
Chancery of the State of Delaware, upon application by a stockholder, shall determine otherwise. In determining the validity and counting
of proxies and ballots cast at any meeting of stockholders, the inspector may consider such information as is permitted by applicable
law. No person who is a candidate for office at an election may serve as an inspector at such election.
Section 1.9. Voting.
Except as otherwise required by the rules or regulations of any
stock exchange applicable to the Corporation, any law or regulation applicable to the Corporation or by the Certificate of Incorporation
or these bylaws, all matters other than the election of directors shall be determined by a majority
of the votes cast on the matter affirmatively or negatively. When a quorum is present at any meeting of stockholders, a nominee
for director shall be elected to the Board of Directors if the votes properly cast for such nominee’s election exceed the votes
properly cast against such nominee’s election (with “abstentions” and “broker
non-votes” not counted as votes cast either “for” or “against” any proposal); provided, however,
that directors shall be elected by a plurality of the votes properly cast at any meeting of stockholders at which there is a contested
election of directors. An election shall be considered contested if as of the record date of any meeting of stockholders there are more
nominees for election than positions on the Board of Directors to be filled by election at that meeting.
Section 1.10. Stock List.
A
complete list of stockholders of the Corporation entitled to vote at any meeting of stockholders of the Corporation, arranged in alphabetical
order for each class of stock and showing the address of each such stockholder and the number of shares registered in the name of such
stockholder, shall be open to the examination of any such stockholder, for any purpose germane to a meeting of the stockholders of the
Corporation, for a period of at least ten (10) days ending on the day before the meeting (i) on a reasonably accessible electronic
network, provided that the information required to gain access to such list is provided with the notice of the meeting or (ii) during
ordinary business hours at the principal place of business of the Corporation; provided, however, if the record date for
determining the stockholders entitled to vote is less than ten (10) days before the meeting date, the list shall reflect the stockholders
entitled to vote as of the tenth (10th) day before such meeting date. The Corporation may
look to this list as the sole evidence of the identity of the stockholders entitled to vote at a meeting and the number of shares held
by each stockholder.
SECTION 2 - BOARD OF DIRECTORS
Section 2.1. General Powers and Qualifications of Directors.
The business and affairs of the Corporation shall be managed by or
under the direction of the Board of Directors. In addition to the powers and authorities that these bylaws expressly confer upon them,
the Board of Directors may exercise all such powers of the Corporation and do all such lawful acts and things as are not by the DGCL,
the Certificate of Incorporation or these bylaws required to be exercised or done by the stockholders. Directors need not be stockholders
of the Corporation to be qualified for election or service as a director of the Corporation.
Section 2.2. Removal; Resignation.
The directors of the Corporation may be removed in accordance with
the Certificate of Incorporation and the DGCL. Any director may resign at any time upon notice given in writing, including by electronic
transmission, to the Corporation. A resignation shall be effective upon receipt, unless the resignation otherwise provides.
Section 2.3. Regular Meetings.
Regular meetings of the Board of Directors shall be held at the place,
if any, on the date and at the time as shall have been established by the Board of Directors and publicized among all directors. A notice
of a regular meeting, the date of which has been so publicized, shall not be required.
Section 2.4. Special Meetings.
Special meetings of the Board of Directors may be called by (i) the
Chairperson of the Board of Directors, (ii) the Chief Executive Officer of the Corporation, or (iii) two or more directors then
in office, and shall be held at the place, if any, on the date and at the time as he, she or they shall fix. Notice of the place, if any,
date and time of each special meeting shall be given to each director either (x) by mailing written notice thereof not less than
five days before the meeting, or (y) by telephone, e-mail or other means of electronic transmission providing notice thereof not
less than twenty-four hours before the meeting. Any and all business may be transacted at a special meeting of the Board of Directors.
Section 2.5. Quorum.
At any meeting of the Board of Directors, a majority of the total number
of directors then in office shall constitute a quorum for all purposes. If a quorum shall fail to attend any meeting, a majority of those
present may adjourn the meeting to another place, if any, date or time, without further notice or waiver thereof.
Section 2.6. Participation in Meetings by Conference Telephone,
Video Conference or Other Communications Equipment.
Members of the Board of Directors, or of any committee thereof, may
participate in a meeting of the Board of Directors or committee thereof by means of conference telephone, video conference or other communications
equipment by means of which all directors participating in the meeting can hear each other director, and such participation shall constitute
presence in person at the meeting.
Section 2.7. Conduct of Business.
At any meeting of the Board of Directors, business shall be transacted
in the order and manner that Chairperson of the Board of Directors determines, and all matters shall be determined by the vote of a majority
of the directors present, provided a quorum is present at the time such matter is acted upon, except as otherwise provided in the Certificate
of Incorporation or these bylaws or required by applicable law. The Board of Directors or any committee thereof may take action without
a meeting if all members thereof consent thereto in writing, including by electronic transmission, and the writing or writings, or electronic
transmission or electronic transmissions, are filed with the minutes of proceedings of the Board of Directors and committee thereof. Such
filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained
in electronic form.
Section 2.8. Compensation of Directors.
The Board of Directors shall be authorized to fix the compensation
of directors. The directors of the Corporation shall be paid their expenses, if any, of attendance at each meeting of the Board of Directors
and may be reimbursed a fixed sum for attendance at each meeting of the Board of Directors, paid an annual retainer or paid other compensation,
including equity compensation, as the Board of Directors determines. No such payment shall preclude any director from serving the Corporation
in any other capacity and receiving compensation therefor. Members of committees shall have their expenses, if any, of attendance of each
meeting of such committee reimbursed and may be paid compensation for attending committee meetings or being a member of a committee.
SECTION 3 - COMMITTEES
The Board of Directors may designate committees of the Board of Directors,
with such lawfully delegable powers and duties as it thereby confers, to serve at the pleasure of the Board of Directors and shall, for
those committees, appoint a director or directors to serve as the member or members, designating, if it desires, other directors as alternate
members who may replace any absent or disqualified member at any meeting of such committee. In the absence or disqualification of any
member of any committee and any alternate member in his or her place, the member or members of the committee present at the meeting and
not disqualified from voting, whether or not he or she or they constitute a quorum, may by unanimous vote appoint another member of the
Board of Directors to act at the meeting in the place of the absent or disqualified member, provided that such other member satisfied
all applicable criteria for membership on such committee. All provisions of this Section 3 are subject to, and nothing in this Section 3
shall in any way limit the exercise, or method or timing of the exercise of, the rights of any person granted by the Corporation with
respect to the existence, duties, composition or conduct of any committee of the Board of Directors.
SECTION 4 - OFFICERS
Section 4.1. Generally.
The officers of the Corporation shall consist of a Chief Executive
Officer, President, one or more Vice Presidents, a Treasurer, a Secretary and other officers as may from time to time be appointed by
the Board of Directors. Each officer shall hold office until his or her successor is elected and qualified or until his or her earlier
death, resignation or removal. Any number of offices may be held by the same person. The salaries of officers appointed by the Board of
Directors shall be fixed from time to time by the Board of Directors or a committee thereof or by the officers as may be designated by
resolution of the Board of Directors.
Section 4.2. Chief Executive Officer.
The Chief Executive Officer shall, subject to the provisions of these
bylaws and to the direction of the Board of Directors, have general charge and supervision of the business of the Corporation and shall
perform all duties and have all powers that are commonly incident to the office of chief executive officer or which are delegated to him
or her by the Board of Directors. He or she shall have the power to sign all stock certificates, contracts and other instruments of the
Corporation that are authorized and shall have general supervision and direction of all of the other officers, employees and agents of
the Corporation.
Section 4.3. President.
The President shall have the powers and duties delegated to him or
her by the Board of Directors or the Chief Executive Officer. The Chief Executive Officer shall be the President, unless the Board of
Directors appoints a different individual.
Section 4.4. Vice Presidents.
Each Vice President shall have the powers and duties delegated to him
or her by the Board of Directors, the Chief Executive Officer, or the President. One Vice President may be designated by the Board of
Directors to perform the duties and exercise the powers of the Chief Executive Officer or President in the event of such officer’s
absence or disability. The Board of Directors may assign to any Vice President the title of Executive Vice President, Senior Vice President
or any title selected by the Board of Directors.
Section 4.5. Treasurer.
The Treasurer shall have the responsibility for maintaining the financial
records of the Corporation. He or she shall make such disbursements of the funds of the Corporation as are authorized and shall render
from time to time an account to the Board of Directors of all such transactions and of the financial condition of the Corporation. The
Treasurer shall also perform other duties as the Board of Directors may from time to time prescribe. The Treasurer shall have the power
to appoint an Assistant Treasurer to assist the Treasurer in carrying out his or her responsibilities.
Section 4.6. Secretary.
The Secretary shall issue all authorized notices for, and shall keep
minutes of, all meetings of the stockholders and the Board of Directors. He or she shall have charge of the corporate books and shall
perform other duties as the Board of Directors may from time to time prescribe. The Secretary shall have the power to appoint one or more
Assistant Secretaries to assist the Secretary in carrying out his or her responsibilities.
Section 4.7. Delegation of Authority.
The Board of Directors may from time to time delegate the powers or
duties of any officer to any other officer or agent, notwithstanding any provision hereof.
Section 4.8. Removal.
The Board of Directors may remove any officer of the Corporation at
any time, with or without cause, without prejudice to the rights, if any, of such officer under any contract to which the Corporation
or any of its subsidiaries is a party, and such removal shall be effective upon receipt, unless the Board of Directors provides otherwise.
Any officer may resign at any time upon written notice to the Corporation, without prejudice to the rights, if any, of the Corporation
under any contract to which such officer is a party, and such resignation shall be effective upon receipt, unless the resignation otherwise
provides. If any vacancy occurs in any office of the Corporation, the Board of Directors may elect a successor to fill such vacancy for
the remainder of the unexpired term and until a successor shall have been duly chosen and qualified.
Section 4.8. Action with Respect to Securities of Other Companies.
Unless otherwise directed by the Board of Directors, the Chief Executive
Officer, the President, or any officer of the Corporation authorized by the Chief Executive Officer or President, shall have power to
vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of stockholders or equityholders of, or with
respect to any action of, stockholders or equityholders of any other entity in which the Corporation may hold securities and otherwise
to exercise any and all rights and powers which the Corporation may possess by reason of its ownership of securities in such other entity.
SECTION 5 - STOCK
Section 5.1. Certificates of Stock.
Shares of the capital stock of the Corporation may be certificated
or uncertificated, as provided in the DGCL. Stock certificates shall be signed by, or in the name of the Corporation by any two authorized
officers of the Corporation, certifying the number of shares owned by such stockholder. Any signatures on a certificate may be by facsimile.
Although any officer, transfer agent or registrar whose manual or facsimile signature is affixed to such a certificate ceases to be such
officer, transfer agent or registrar before such certificate has been issued, it may nevertheless be issued by the Corporation with the
same effect as if such officer, transfer agent or registrar were still such at the date of its issue.
Section 5.2. Transfers of Stock.
Transfers of stock shall be made only upon the transfer books of the
Corporation kept at an office of the Corporation (within or without the State of Delaware) or by transfer agents designated to transfer
shares of the stock of the Corporation.
Section 5.3. Lost, Stolen or Destroyed Certificates.
In the event of the loss, theft or destruction of any certificate of
stock, another may be issued in its place pursuant to regulations as the Board of Directors may establish concerning proof of the loss,
theft or destruction and concerning the giving of a satisfactory bond or indemnity.
Section 5.4. Regulations.
The issue, transfer, conversion and registration of certificates of
stock of the Corporation shall be governed by other regulations as the Board of Directors may establish.
Section 5.5. Record Date.
(a) In order that the Corporation may determine the stockholders
entitled to notice of any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record
date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record
date shall, unless otherwise required by law, not be more than sixty (60) nor less than ten (10) days before the date of such meeting.
If the Board of Directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at
such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date
of the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date
for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day
preceding the day on which notice is given, or, if notice is waived, at the close of business on the day preceding the day on which the
meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to
any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for determination
of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled
to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance
herewith at the adjourned meeting.
(b) In order that the Corporation may determine the stockholders
entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect
of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record
date, which shall not be more than sixty (60) days prior to such other action. If no such record date is fixed, the record date for determining
stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating
thereto.
SECTION 6 - NOTICES
Section 6.1. Notices.
Except as otherwise provided herein or permitted by applicable law,
notices to directors and stockholders shall be in writing and delivered personally or mailed to the directors or stockholders at their
addresses appearing on the books of the Corporation. If mailed, notice to a stockholder of the Corporation shall be deemed given when
deposited in the mail, postage prepaid, directed to a stockholder at such stockholder’s address as it appears on the records of
the Corporation. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders
of the Corporation may be given by electronic transmission in the manner provided in Section 232 of the DGCL.
Section 6.2. Waivers.
A written waiver of any notice, signed by a stockholder or director,
or a waiver by electronic transmission by such person or entity, whether given before or after the time of the event for which notice
is to be given, shall be deemed equivalent to the notice required to be given to such person or entity. Neither the business nor the purpose
of any meeting need be specified in the waiver. Attendance at any meeting shall constitute waiver of notice except attendance for the
sole purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called
or convened.
SECTION 7 - MISCELLANEOUS
Section 7.1. Corporate Seal.
The Board of Directors may provide a suitable seal, containing the
name of the Corporation, which seal shall be in the charge of the Secretary. If and when so directed by the Board of Directors, duplicates
of the seal may be kept and used by the Treasurer or by an Assistant Secretary or Assistant Treasurer.
Section 7.2. Reliance upon Books, Reports, and Records.
Each director and each member of any committee designated by the Board
of Directors shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books and records of
the Corporation and upon such information, opinions, reports or statements presented to the Corporation by any of its officers, agents
or employees, or committees of the Board of Directors, or by any other person or entity as to matters which such director or committee
member reasonably believes are within such other person’s or entity’s professional or expert competence and that has been
selected with reasonable care by or on behalf of the Corporation.
Section 7.3. Fiscal Year.
The fiscal year of the Corporation shall be the calendar year or as
otherwise fixed by the Board of Directors.
Section 7.4. Time Periods.
In applying any provision of these bylaws that requires that an act
be done or not be done a specified number of days before an event or that an act be done during a specified number of days before an event,
calendar days shall be used, the day of the doing of the act shall be excluded, and the day of the event shall be included.
SECTION 8 - AMENDMENTS
These bylaws may be altered, amended or repealed in accordance with
the Certificate of Incorporation and the DGCL.
SECTION 9 - SEVERABILITY
If any provision or provisions of these bylaws shall be held to be
invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever: (i) the validity, legality and enforceability
of such provisions in any other circumstance and of the remaining provisions of these bylaws (including, without limitation, each portion
of any paragraph of these bylaws containing any such provision held to be invalid, illegal or unenforceable that is not itself held to
be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and (ii) to the fullest extent possible,
the provisions of these bylaws (including, without limitation, each such portion of any paragraph of these bylaws containing any such
provision held to be invalid, illegal or unenforceable) shall be construed so as to permit the Corporation to protect its directors, officers,
employees and agents from personal liability in respect of their good faith service to or for the benefit of the Corporation to the fullest
extent permitted by law.
v3.24.3
Cover
|
Oct. 15, 2024 |
Cover [Abstract] |
|
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Oct. 15, 2024
|
Current Fiscal Year End Date |
--12-31
|
Entity File Number |
001-42365
|
Entity Registrant Name |
CAMP4 THERAPEUTICS CORPORATION
|
Entity Central Index Key |
0001736730
|
Entity Tax Identification Number |
81-1152476
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
One Kendall Square
|
Entity Address, Address Line Two |
Building 1400 West, 3rd Floor
|
Entity Address, City or Town |
Cambridge
|
Entity Address, State or Province |
MA
|
Entity Address, Postal Zip Code |
02139
|
City Area Code |
617
|
Local Phone Number |
651-8867
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Title of 12(b) Security |
Common Stock, par value $0.0001 per share
|
Trading Symbol |
CAMP
|
Security Exchange Name |
NASDAQ
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
CAMP4 Therapeutics (NASDAQ:CAMP)
過去 株価チャート
から 11 2024 まで 12 2024
CAMP4 Therapeutics (NASDAQ:CAMP)
過去 株価チャート
から 12 2023 まで 12 2024